Ingevity Corp Files 8-K: Director, Officer, and Compensation Updates

Ticker: NGVT · Form: 8-K · Filed: 2025-10-23T00:00:00.000Z

Sentiment: neutral

Topics: corporate-governance, officer-changes, compensation

Related Tickers: NGVT

TL;DR

NGVT filed an 8-K on Oct 23, 2025, covering director/officer changes and comp plans. Watch for details.

AI Summary

On October 23, 2025, Ingevity Corporation filed an 8-K report detailing changes in its board of directors and certain officers, along with updates to compensatory arrangements. The filing also includes information on Regulation FD disclosures and financial statements/exhibits. Specific details regarding the individuals involved or the nature of the compensatory arrangements were not provided in the excerpt.

Why It Matters

This filing indicates potential shifts in corporate governance and executive compensation at Ingevity, which could impact the company's strategic direction and investor relations.

Risk Assessment

Risk Level: low — The filing is routine and reports on corporate governance and compensation, not immediate financial distress or major strategic shifts.

Key Players & Entities

FAQ

What specific changes were made to Ingevity Corporation's board of directors or certain officers?

The filing indicates changes in directors or certain officers, but the specific details of these changes are not provided in the excerpt.

What is the nature of the updates to the compensatory arrangements of certain officers?

The filing mentions updates to compensatory arrangements for certain officers, but the specific details of these arrangements are not included in the provided text.

What is the filing date of this 8-K report?

The filing date of this 8-K report is October 23, 2025.

What is the state of incorporation for Ingevity Corporation?

Ingevity Corporation is incorporated in Delaware.

What is the SIC code for Ingevity Corporation?

The Standard Industrial Classification (SIC) code for Ingevity Corporation is 2800 (Chemicals & Allied Products).

Filing Stats: 746 words · 3 min read · ~2 pages · Grade level 11.7 · Accepted 2025-10-23 06:37:31

Key Financial Figures

Filing Documents

01. REGULATION FD DISCLOSURE

ITEM 7.01. REGULATION FD DISCLOSURE A copy of the press release announcing the appointment of Ms. Castillo as Senior Vice President and President, Performance Materials of Ingevity is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

01. FINANCIAL STATEMENTS AND EXHIBITS

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS (d) Exhibits. Exhibit No. Description of Exhibit 99.1 Press release dated October 23, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INGEVITY CORPORATION (Registrant) By: /S/ RYAN C. FISHER Ryan C. Fisher Senior Vice President, General Counsel and Corporate Secretary Date: October 23, 2025

View on Read The Filing